Skip to main content
. 2022 Feb 14;3(3):e143–e152. doi: 10.1016/S2666-7568(22)00009-5

Figure 3.

Figure 3

Association of COVID-19 and Cancer Consortium geriatric risk index with COVID-19 severity and 30-day all-cause mortality among older adults with cancer

Model for COVID-19 severity adjusted for sex, race and ethnicity, smoking status, obesity, type of malignancy, cancer status, recent (within 3 months) anti-cancer therapies (cytotoxic chemotherapy, targeted therapy, endocrine therapy, immunotherapy, locoregional therapy), country of patient residence, and month of COVID-19 diagnosis; all variance inflation factors <1·6. Model for 30-day all-cause mortality adjusted for sex, race and ethnicity, smoking status, obesity, type of malignancy, cancer status, recent (within 3 months) anti-cancer therapies (cytotoxic chemotherapy, endocrine therapy, immunotherapy, locoregional therapy), country of patient residence, and month of COVID-19 diagnosis; all variance inflation factors <1·7. OR=odds ratio. *ORs relative to standard-risk patients.